Manuva13
Re: Your "Dreaming"
Thanks for your post and insight.
Would you send a communication to LBT for us and ask them to confirm or deny your sentiment.
Why?
Given that LBT modus operandi is to actually find inefficiencies in a business and automate it with braininess / invention and to create serious reduction in OPEX for companies.
AND
They get "denovo" in "FDAland"... they seem to think it's worth giving a tick.
AND
LBT get lots and lots of grants for being awesome with invention and helping "dare I say it" the greater good and / serious cost savings and quicker throughput (for quicker diagnosis).
THEN
If what you say is true then "WHY BOTHER"?
Why would FDA, Governments etc give grants to something that is not that good or not awesome. I mean if it was not much ($70k a year for a MEDIUM business), FDA would not of created a category for us in the first place.
LBT haven't said what you have said - quite the contrary.
So:
1. If you are right - please would you get a confirmation from them - They have always answered my emails.
2. There has been a lot of inference regarding pathologists security of their jobs. There is quite a lot of politics going here - as I understand it...Is this true?
a. If it is true - then they more than likely want to protect their jobs from the type of equipment LBT is offering the market. So it actually is awesome-ness.
b. If it is not true - and the reality is what you say....then why would the pathologists even worry about LBT.
BTW - The above is all with due respect..
If you are right - I would love for it to be confirmed.
If you are not "as right" as you are purporting and LBT's offering is still awesome (but has to get in between politics and reality) - then I will keep this stock as a buy.
- Forums
- ASX - By Stock
- LBT
- Outcome from JP Morgan conference?
Outcome from JP Morgan conference?, page-24
Featured News
Add LBT (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.8¢ |
Change
0.002(12.5%) |
Mkt cap ! $31.63M |
Open | High | Low | Value | Volume |
1.7¢ | 1.8¢ | 1.7¢ | $3.899K | 228.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 361155 | 1.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.8¢ | 1523195 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 361155 | 0.017 |
5 | 750000 | 0.016 |
6 | 2349998 | 0.015 |
7 | 1238571 | 0.014 |
3 | 183461 | 0.013 |
Price($) | Vol. | No. |
---|---|---|
0.018 | 1523195 | 7 |
0.019 | 381203 | 2 |
0.021 | 322878 | 2 |
0.023 | 500000 | 1 |
0.024 | 200000 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
LBT (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online